250 studies found for:    (North Carolina) [LOCATION-STATE] AND (prostate cancer) [CONDITION]
Show Display Options
Rank Status Study
1 Recruiting Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Conditions: Prostate Cancer;   Castration Resistant Prostate Cancer;   Pain;   Prostatic Neoplasms
Interventions: Drug: cabozantinib;   Drug: mitoxantrone;   Drug: prednisone
2 Completed Satraplatin in Hormone Refractory Prostate Cancer Patients Previously Treated With One Cytotoxic Chemotherapy Regimen
Conditions: Prostate Cancer;   Hormone Refractory Prostate Cancer
Interventions: Drug: Satraplatin;   Drug: Prednisone
3 Recruiting Enzalutamide With or Without Abiraterone Acetate and Prednisone in Treating Patients With Castration-Resistant Metastatic Prostate Cancer
Conditions: Adenocarcinoma of the Prostate;   Hormone-resistant Prostate Cancer;   Recurrent Prostate Cancer;   Stage IV Prostate Cancer
Interventions: Drug: enzalutamide;   Drug: abiraterone;   Drug: prednisone
4 Active, not recruiting CyberKnife Radiosurgery For Low & Intermediate Risk Prostate Cancer: Emulating HDR Brachytherapy Dosimetry
Conditions: Prostate Cancer;   Prostatic Cancer;   Prostatic Neoplasms;   Prostate Neoplasms;   Cancer of the Prostate
Intervention: Radiation: CyberKnife Stereotactic Radiosurgery
5 Active, not recruiting Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100
Conditions: Prostate Cancer;   Castration Resistant Prostate Cancer;   Pain;   Prostatic Neoplasms
Interventions: Drug: cabozantinib;   Drug: prednisone
6 Recruiting Study of Cabozantinib in Combination With Abiraterone in Chemotherapy-Naïve Subjects With Bone-Metastatic Castration-Resistant Prostate Cancer
Conditions: Prostate Cancer;   Castration Resistant Prostate Cancer;   Prostatic Neoplasms
Interventions: Drug: cabozantinib;   Drug: abiraterone;   Drug: prednisone
7 Active, not recruiting Androgen Deprivation Therapy and Vorinostat Followed by Radical Prostatectomy in Treating Patients With Localized Prostate Cancer
Conditions: Adenocarcinoma of the Prostate;   Stage I Prostate Cancer;   Stage IIA Prostate Cancer;   Stage IIB Prostate Cancer;   Stage III Prostate Cancer
Interventions: Drug: bicalutamide;   Drug: leuprolide acetate;   Drug: goserelin acetate;   Drug: vorinostat;   Procedure: therapeutic conventional surgery;   Other: laboratory biomarker analysis
8 Active, not recruiting S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Conditions: Breast Cancer;   Lung Cancer;   Metastatic Cancer;   Multiple Myeloma;   Plasma Cell Neoplasm;   Prostate Cancer;   Unspecified Adult Solid Tumor, Protocol Specific
Intervention: Procedure: assessment of therapy complications
9 Completed Soy Protein/Isoflavones and Venlafaxine in Treating Hot Flashes in Patients Receiving Hormone Therapy for Prostate Cancer
Conditions: Hot Flashes;   Prostate Cancer
Interventions: Dietary Supplement: soy isoflavones;   Dietary Supplement: soy protein isolate;   Drug: venlafaxine;   Drug: placebo
10 Terminated S0437 Long-Term Follow-Up of Patients Who Were Diagnosed With Prostate Cancer on PCPT
Condition: Prostate Cancer
Intervention: Other: Follow-up
11 Completed Lapatinib in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy
Condition: Prostate Cancer
Intervention: Drug: lapatinib ditosylate
12 Active, not recruiting Bicalutamide and Goserelin or Leuprolide Acetate With or Without Cixutumumab in Treating Patients With Newly Diagnosed Metastatic Prostate Cancer
Conditions: Adenocarcinoma of the Prostate;   Recurrent Prostate Cancer;   Stage IV Prostate Cancer
Interventions: Drug: bicalutamide;   Drug: goserelin acetate;   Drug: leuprolide acetate;   Biological: cixutumumab;   Other: laboratory biomarker analysis;   Other: pharmacological study
13 Recruiting Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
Conditions: Distal Urethral Cancer;   Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter;   Proximal Urethral Cancer;   Recurrent Bladder Cancer;   Recurrent Prostate Cancer;   Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter;   Recurrent Urethral Cancer;   Stage IV Bladder Cancer;   Stage IV Prostate Cancer;   Transitional Cell Carcinoma of the Bladder;   Urethral Cancer Associated With Invasive Bladder Cancer
Interventions: Drug: gemcitabine hydrochloride;   Drug: cisplatin;   Other: placebo;   Biological: bevacizumab;   Other: laboratory biomarker analysis
14 Active, not recruiting Radiation Therapy With or Without Bicalutamide in Treating Patients With Stage II, Stage III, or Recurrent Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: bicalutamide;   Radiation: low-LET cobalt-60 gamma ray therapy;   Radiation: low-LET photon therapy
15 Active, not recruiting Radiation Therapy, Androgen Suppression, and Docetaxel in Treating Patients With High-Risk Prostate Cancer Who Have Undergone Radical Prostatectomy
Condition: Prostate Cancer
Interventions: Drug: bicalutamide;   Drug: docetaxel;   Drug: flutamide;   Drug: goserelin acetate;   Drug: leuprolide acetate;   Procedure: adjuvant therapy;   Radiation: 3-dimensional conformal radiation therapy;   Radiation: intensity-modulated radiation therapy
16 Recruiting Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: docetaxel;   Drug: goserelin acetate;   Drug: leuprolide acetate;   Procedure: conventional surgery
17 Recruiting Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Condition: Prostate Cancer
Interventions: Radiation: radiation therapy;   Radiation: Whole-pelvic radiotherapy (WPRT)
18 Active, not recruiting Hormone Therapy and Radiation Therapy or Hormone Therapy and Radiation Therapy Followed by Docetaxel and Prednisone in Treating Patients With Localized Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: bicalutamide;   Drug: buserelin;   Drug: docetaxel;   Drug: flutamide;   Drug: goserelin acetate;   Drug: leuprolide acetate;   Drug: prednisone;   Drug: triptorelin;   Radiation: radiation therapy
19 Active, not recruiting Zoledronate in Preventing Osteoporosis and Bone Fractures in Patients With Locally Advanced Nonmetastatic Prostate Cancer Undergoing Radiation Therapy and Hormone Therapy
Conditions: Osteoporosis;   Prostate Cancer
Interventions: Dietary Supplement: calcium carbonate;   Dietary Supplement: calcium citrate;   Dietary Supplement: calcium glucarate;   Dietary Supplement: cholecalciferol;   Drug: buserelin;   Drug: calcium gluconate;   Drug: goserelin acetate;   Drug: leuprolide acetate;   Drug: triptorelin;   Drug: zoledronic acid;   Radiation: brachytherapy;   Radiation: radiation therapy
20 Completed Exercise and Dietary Counseling in Improving Physical Activity, Nutrition, and Quality of Life in Older Long-Term Cancer Survivors Who Are Overweight
Conditions: Breast Cancer;   Colorectal Cancer;   Prostate Cancer
Intervention: Behavioral: behavioral dietary and exercise intervention

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years